Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors
US8865726B2 · kind B2 · utility
0Cited by
0References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2010 |
| Grant date | Oct 21, 2014 |
| Priority date | — |
| Expiry date | May 4, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formula I: and salts thereof in which R1, R2, R2a, R3, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.